Goldman Sachs

Goldman Sachs is a global investment banking, securities, and investment management firm headquartered in New York City. Established in 1869, it provides a wide range of financial services to corporations, financial institutions, governments, and high-net-worth individuals. The firm operates through several segments, including Investment Banking, which offers financial advisory services related to mergers and acquisitions, and underwriting services for public and private offerings. Its Institutional Client Services segment facilitates client transactions across various asset classes and provides services like securities lending. The Investing & Lending segment focuses on long-term loans and investments in debt and equity securities, while the Investment Management segment offers portfolio management and wealth advisory services. Additionally, Goldman Sachs engages in private equity investments across multiple sectors and geographies, reinforcing its position as a leading investor in both public and private markets.

Raanan A. Agus

MD, Co-Head of the GSIS Portfolio Management Team and Portfolio Manager

Julian Allen

Chief Operating Officer of Infrastructure Investment Group

Jeffrey A. Barclay

MD

Merrick M. Elfman

Pharmacy Operations

J. Brent Humphries

Director

Luisa Leyenaar

Managing Director

Robert Magnuson

MD, Head of High Yield Strategies & Portfolio Manager

David Solomon

President and Chief Operating Officer

Suwabe C.M.A., Ph.D., Takashi

MD & Portfolio Manager

Past deals in Maryland

Viela Bio

Series B in 2019
Viela Bio, Inc. is a clinical-stage biotechnology company based in Gaithersburg, Maryland, focused on developing treatments for severe inflammation and autoimmune diseases. Its lead product candidate, inebilizumab, is a humanized monoclonal antibody targeting CD19, aimed at treating conditions such as neuromyelitis optica spectrum disorder, kidney transplant desensitization, myasthenia gravis, and IgG4-related diseases. The company is also advancing additional candidates, including VIB4920 for kidney transplantation rejection and Sjögren’s syndrome, as well as VIB7734 for cutaneous lupus erythematosus. Viela Bio has formed a strategic collaboration with Mitsubishi Tanabe Pharma Corporation to develop and commercialize inebilizumab for autoimmune diseases across several countries in Asia. Founded in 2017, the company is dedicated to addressing unmet medical needs in the field of autoimmune disorders.

iControl Systems

Venture Round in 2015
iControl Systems provides innovative solutions for the retail industry, enabling over 50,000 retail locations and 4,000 distributors to enhance their operational efficiency. The company specializes in scan-based inventory and payment systems, which automate data synchronization between retailers and their vendors. This technology facilitates the transmission and verification of financial transactions, streamlining the reconciliation of billing errors. Additionally, iControl Systems offers tools for performance evaluation and forecasting, helping businesses optimize their inventory management and financial processes. Through these services, iControl Systems plays a crucial role in improving the accuracy and effectiveness of retail operations.

DrFirst

Venture Round in 2015
DrFirst is a software solution provider focused on enhancing healthcare delivery for physicians and other healthcare providers. The company offers a range of services, including HIPAA secure messaging, e-prescribing, electronic health records (EHR), and hospital medication reconciliation. DrFirst's software is designed to serve pharmacies, hospitals, and post-acute care facilities by providing real-time access to patient data. This facilitates improved communication and collaboration among caregivers, thereby enhancing the clinical view of patients and supporting better health outcomes.

Credible Behavioral Health, Inc.

Venture Round in 2015
Credible provides easy to use software for clinic, community, residential, and mobile care providers. A SaaS vendor, Credible offers a Behavioral Health Electronic Record (EHR) is HIPAA compliant. The company is committed to providing innovation, ease of use, and optimization runs throughout the company and its software. It provides clinical, scheduling, billing, form management, eRx, eLabs, mobile/field, reporting, and business intelligence modules. in 2000, Matthew M. Dorman founded the company in Rockville, Maryland.

Current Communications Group

Venture Round in 2011
CURRENT provides electric utilities a Smart Grid solution that increases the efficiency and reliability of the electric grid while reducing the environmental impact of electric usage. Their integrated solution combines advanced sensing technology, two-way high-speed communications, 24/7 monitoring and enterprise analysis software and related services to provide location-specific, real-time actionable data. CURRENT is also a fully-integrated communications service provider, with the capability to offer high-performance broadband services and home energy management services to every plug in every home or office using the electric wires.

Tervela

Series C in 2008
Tervela, Inc. specializes in designing and developing a Data in Motion platform that facilitates the movement, integration, and analysis of data across various environments. Its key offerings include Data Fabric, a messaging software platform that enables users to capture and distribute data from multiple enterprise and cloud sources; Cloud FastPath, an automated service for secure migration and synchronization of digital content between on-premise and cloud infrastructures; and NetCharts, a comprehensive suite for data visualization and performance management. These solutions are aimed at addressing time-consuming tasks such as data ingest, cloud integration, and analysis, making them valuable to both small businesses and large corporations. Founded in 2004, Tervela is headquartered in Boston, Massachusetts, with additional locations in Brooklyn, New York, and Owings Mills, Maryland.

CeLight

Series B in 2001
CeLight Inc. specializes in the research, development, and sale of opto-electronic sub-systems and integrated electro-optical components. The company is renowned for its VectorWAVE technology, a digital platform that integrates coherent optical technology with digital signal processing to effectively synthesize, transmit, receive, and analyze coherent optical signals. This technology supports various applications, including the standoff detection of explosives and chemicals, secure optical communications, remote sensing, and signal intelligence. In addition to its product offerings, CeLight provides customized services that include analysis, simulation, design, and fabrication related to advanced optical transmission technologies. Founded in 1999 and based in Silver Spring, Maryland, CeLight serves a diverse range of sectors, including military, homeland security, government, and commercial markets.

Gene Logic

Venture Round in 1997
Gene Logic is a leading integrated genomics company providing comprehensive Genomic Reference Databases and GLP compliant Microarray Services. Over 2/3rd of the top 25 Pharma companies, leading research institutes and emerging biotech companies worldwide have chosen us as their preferred genomics partner and utilize our expertise for understanding underlying mechanisms of diseases, discovery and prioritization of gene targets & biomarkers.